This innovative method promoted continuous arginine supplementation in murine colorectal carcinoma tumors, leading to increased CD8+ T cell infiltration and synergistic anti-tumor effects when combined with anti-PD-L1 treatment[159]. Here, CD274 is linked to colorectal carcinoma.